Precigen (PGEN) Return on Invested Capital (2014 - 2023)
Precigen's (PGEN) quarterly Return on Invested Capital came in at 0.03% in Q4 2023, down 2.0% year-on-year from 0.03% in Q4 2022, and down 215.14% on a QoQ basis from 0.01% in Q3 2023.
Precigen (PGEN) Return on Invested Capital (2014 - 2023) Analysis & Trends
Precigen (PGEN) has 10 years of Return on Invested Capital data on file, last reported at 0.03% in Q4 2023.
- On a quarterly basis, Return on Invested Capital fell 2.0% year-over-year to 0.03% in Q4 2023; TTM through Dec 2023 was 0.03%, a 2.0% decrease from a year earlier, with the FY2022 full-year figure at 0.03%, up 1971.0% from the prior year.
- Return on Invested Capital for Q4 2023 stood at 0.03%, down from 0.01% in the prior quarter.
- Over the last five years, Return on Invested Capital for PGEN reached as high as 0.01% in Q2 2023 and fell as low as 3.65% in Q2 2020.
- Historically, Return on Invested Capital has averaged 1.31% across 5 years, with a median of 1.09% in 2020.
- Across the five-year window, Return on Invested Capital sank 238 bps in 2020 and surged 205 bps in 2022, its largest moves.
- Year by year, Return on Invested Capital stood at 0.67% in 2019, then sank by 268 bps to 2.48% in 2020, then soared by 57 bps to 1.08% in 2021, then surged by 99 bps to 0.01% in 2022, then sank by 286 bps to 0.03% in 2023.
- Per Business Quant data, the three most recent Return on Invested Capital figures were 0.03% in Q4 2023, 0.01% in Q3 2023, and 0.01% in Q2 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 0.00% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 0.04% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Precigen | 1.96 Bn | 1.96 Bn | 20.69 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2023 | -0.03% |
| Sep 30, 2023 | -0.01% |
| Jun 30, 2023 | -0.01% |
| Mar 31, 2023 | -0.01% |
| Dec 31, 2022 | -0.01% |
| Sep 30, 2022 | -0.02% |
| Jun 30, 2022 | -0.98% |
| Mar 31, 2022 | -1.03% |
| Dec 31, 2021 | -1.08% |
| Sep 30, 2021 | -1.66% |
| Jun 30, 2021 | -3.03% |
| Mar 31, 2021 | -3.02% |
| Dec 31, 2020 | -2.48% |
| Sep 30, 2020 | -3.07% |
| Jun 30, 2020 | -3.65% |
| Mar 31, 2020 | -1.10% |
| Dec 31, 2019 | -0.67% |
| Sep 30, 2019 | -1.36% |
| Jun 30, 2019 | -1.27% |
| Mar 31, 2019 | -1.63% |